Galmed Pharmaceuticals Ltd. GLMD
4.63 USD +0.80 (+21.05%)
At closeSep 9, 2026, 4:00 PM EDT
0.57 -4.06 -87.61%
After hours · Sep 9, 4:00 PM ET
3.82 Day range 4.63
2.56 52-week range 23.80
- YTD
- +516.51%
- 1 year
- +158.66%
GLMD revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | 0 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | -2,038,000 | -100.00% |
| FY 2018 | 2018-12-31 | 2,038,000 | 953,000 | 87.83% |
| FY 2017 | 2017-12-31 | 1,085,000 | 618,000 | 132.33% |
| FY 2016 | 2016-12-31 | 467,000 | 467,000 | Not meaningful |
| FY 2015 | 2015-12-30 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | 0 | Not meaningful |
| FY 2012 | 2012-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-21T06:02:23.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.